Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
At present, our main market covers East and West Africa, Middle East, Southeast Asia, Central America and Europe etc
Further reading [edit] Schnug, E
In the coming years, several trends are likely to emerge: Rapid growth in the number of oral GLP-1 drugs Small-molecule GLP-1 therapies becoming a major R&D focus Manufacturing capacity becoming a key competitive factor Continued entry of emerging biotechnology companies into the sector At the same time, dual-target GLP-1 drugs , GLP-1/GIP co-agonists , and oral multi-target metabolic therapies are also advancing rapidly
Considering these changes in T2DM and the critical role of GLP-1 in glucose homeostasis, strategies for managing T2DM based on this hormone include addressing the differentiation of L-cells, increasing the endogenous production and secretion of GLP-1 through stimulants, extending the half-life of GLP-1 by inhibiting its degrading enzyme and targeting GLP-1R using its agonists
US$ 29.43
US$ 29.24
US$ 23.38
US$ 25.44
US$ 27.95
